Published in BMC Med Imaging on May 05, 2016
Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med (2010) 12.35
Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl (1989) 9.56
Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet (2007) 7.81
Crohn's disease. Lancet (2012) 4.42
Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology (2004) 4.26
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD. Gastrointest Endosc (2004) 4.12
European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut (2006) 3.59
Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut (2009) 2.60
Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives. Gastroenterology (1990) 2.58
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease. Inflamm Bowel Dis (2009) 2.33
Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm Bowel Dis (2010) 2.20
Accuracy of magnetic resonance enterography in assessing response to therapy and mucosal healing in patients with Crohn's disease. Gastroenterology (2013) 2.05
Optimizing anti-TNF treatment in inflammatory bowel disease. Gastroenterology (2004) 1.97
Magnetic resonance imaging for evaluation of Crohn's disease: validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis (2010) 1.91
American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology (2006) 1.78
American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. Gastroenterology (2007) 1.60
National Cooperative Crohn's Disease Study: study design and conduct of the study. Gastroenterology (1979) 1.40
Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gastroenterology (1992) 1.39
Review article: Infliximab therapy for inflammatory bowel disease--seven years on. Aliment Pharmacol Ther (2006) 1.31
Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC. Gastroenterology (2013) 1.03
Serial magnetic resonance imaging for monitoring medical therapy effects in Crohn's disease. Inflamm Bowel Dis (2013) 1.00
TNF alpha secreting cells in normal and diseased human intestine. Adv Exp Med Biol (1995) 0.98
Assessment of activity of Crohn's disease of the ileum and large bowel: proposal for a new multiparameter MR enterography score. Radiol Med (2012) 0.97
Clinical evolution of luminal and perianal Crohn's disease after inducing remission with infliximab: how long should patients be treated? Aliment Pharmacol Ther (2005) 0.94
Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease. J Crohns Colitis (2013) 0.92
Safety, feasibility, and tolerability of ileocolonoscopy in inflammatory bowel disease. Endoscopy (2008) 0.91
Limitations in assessment of mucosal healing in inflammatory bowel disease. World J Gastroenterol (2010) 0.88
Evaluation of treatment response in active Crohn's disease by low-field magnetic resonance imaging. Abdom Imaging (1999) 0.85
Colonoscopic perforations in inflammatory bowel disease: a retrospective study in a French referral centre. Dig Liver Dis (2013) 0.77